Seroatlas · Human Serome Atlas

GLUD1

Glutamate dehydrogenase 1, mitochondrial

Also known as: DHE3_HUMAN, GDH, GDH1, GLUD, hGDH1

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
P00367
Gene
GLUD1
Ensembl
ENSG00000148672
Chromosome
10
Canonical length
558 aa
Protein class
Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins
Subcellular location
Mitochondria
Quaternary structure
Homohexamer

OverviewNCBI Gene

This gene encodes glutamate dehydrogenase, which is a mitochondrial matrix enzyme that catalyzes the oxidative deamination of glutamate to alpha-ketoglutarate and ammonia. This enzyme has an important role in regulating amino acid-induced insulin secretion. It is allosterically activated by ADP and inhibited by GTP and ATP. Activating mutations in this gene are a common cause of congenital hyperinsulinism. Alternative splicing of this gene results in multiple transcript variants. The related glutamate dehydrogenase 2 gene on the human X-chromosome originated from this gene via retrotransposition and encodes a soluble form of glutamate dehydrogenase. Related pseudogenes have been identified on chromosomes 10, 18 and X. [provided by RefSeq, Jan 2016]

Canonical amino-acid sequenceUniProt

558 residues, UniProt reviewed canonical sequence.

>P00367|GLUD1
     1  MYRYLGEALL LSRAGPAALG SASADSAALL GWARGQPAAA PQPGLALAAR RHYSEAVADR
    61  EDDPNFFKMV EGFFDRGASI VEDKLVEDLR TRESEEQKRN RVRGILRIIK PCNHVLSLSF
   121  PIRRDDGSWE VIEGYRAQHS QHRTPCKGGI RYSTDVSVDE VKALASLMTY KCAVVDVPFG
   181  GAKAGVKINP KNYTDNELEK ITRRFTMELA KKGFIGPGID VPAPDMSTGE REMSWIADTY
   241  ASTIGHYDIN AHACVTGKPI SQGGIHGRIS ATGRGVFHGI ENFINEASYM SILGMTPGFG
   301  DKTFVVQGFG NVGLHSMRYL HRFGAKCIAV GESDGSIWNP DGIDPKELED FKLQHGSILG
   361  FPKAKPYEGS ILEADCDILI PAASEKQLTK SNAPRVKAKI IAEGANGPTT PEADKIFLER
   421  NIMVIPDLYL NAGGVTVSYF EWLKNLNHVS YGRLTFKYER DSNYHLLMSV QESLERKFGK
   481  HGGTIPIVPT AEFQDRISGA SEKDIVHSGL AYTMERSARQ IMRTAMKYNL GLDLRTAAYV
   541  NAIEKVFKVY NEAGVTFT

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against GLUD1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Intracellular
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.28
Highest tissue expression
860 nTPM

Expression across tissuesHPA

Tissue

  • liver: 860 nTPM
  • kidney: 265 nTPM
  • cerebral cortex: 140 nTPM
  • amygdala: 124 nTPM
  • basal ganglia: 122 nTPM
  • prostate: 108 nTPM

Single-cell type

  • astrocytes: 574 nCPM
  • respiratory basal cells: 573 nCPM
  • respiratory deuterosomal cells: 546 nCPM
  • hepatocytes: 529 nCPM
  • respiratory secretory cells: 497 nCPM
  • esophageal apical cells: 392 nCPM

Immune cell

  • non-classical monocyte: 14 nTPM
  • myeloid DC: 12 nTPM
  • NK-cell: 10 nTPM
  • T-reg: 10 nTPM
  • classical monocyte: 10 nTPM
  • intermediate monocyte: 9.5 nTPM

Brain region

  • thalamus: 319 nTPM
  • spinal cord: 260 nTPM
  • medulla oblongata: 258 nTPM
  • midbrain: 257 nTPM
  • hypothalamus: 246 nTPM
  • amygdala: 244 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about GLUD1.

Disease | AllUniProt

Conditions GLUD1 is implicated in, by any mechanism.

Disease | GeneticClinVar

15 pathogenic / likely-pathogenic of 319 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.61
gnomAD pLI
0.01
gnomAD missense Z
3.06
DepMap mean gene effect
0.07
DepMap dependency class
none

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of GLUD1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads GLUD1 as an antibody target. Whether an autoantibody or antibody against GLUD1 could matter depends on whether native GLUD1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

GLUD1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label GLUD1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/GLUD1. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...